Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised 10x Genomics, Inc in connection with the acquisition of Spatial Transcriptomics
Mandate

Vinge has advised 10x Genomics, Inc in connection with the acquisition of Spatial Transcriptomics

December 11, 2018 M&A

Spatial Transcriptomics is active within the field of spatial genomics.

 

10x Genomics will continue to operate Spatial Transcriptomics out of their existing offices in Stockholm, with plans to grow their presence in Sweden.

Vinge’s team consisted of, among others, partners Christina Kokko and Kristina Ekberg as well as associates Anna Thoms, Klara Secher, Sophia Holm, Lova Unge, Stina Bengtsson and Frida Ställborn.

Related

Vinge advises Vinci Concessions SAS and its subsidiary SunMind SAS in connection with its acquisition of Helios Nordic Energy AB from Magnora ASA, management and early investors

 Helios Nordic Energy specialises in developing solar farms and batteries to store energy until they become Ready to Build in the Nordics and Baltics.
May 30, 2024

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (“SBB”) in connection with SBB establishing a new joint venture with Castlelake, LP (“Castlelake”).
May 28, 2024

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

 On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024